Skip to content
by Legal Desire
13 September 2021

Latham & Watkins Advises Itamar Medical in Acquisition by ZOLL Medical

Advising firms

Deal team

19 lawyers named
LawyerFirmSeniorityPracticeOffice
Hans Brigham Lead Latham & Watkins LLP Partner corporate Boston
Max Schleusener Lead Latham & Watkins LLP Partner corporate Chicago
Ariel Cho Latham & Watkins LLP Associate corporate Not stated
Nathan Ajiashvili Latham & Watkins LLP Partner capital markets New York
Joshua Kiernan Latham & Watkins LLP Partner capital markets London
Michael Rosenberg Latham & Watkins LLP Counsel capital markets New York
Elizabeth Richards Latham & Watkins LLP Partner FDA regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Counsel FDA regulatory Bay Area
Judith Hasko Latham & Watkins LLP Partner intellectual property Bay Area
Jiqiang Lin Latham & Watkins LLP Associate intellectual property Not stated
Elena Romanova Latham & Watkins LLP Partner tax New York
Shruti Hazra Latham & Watkins LLP Associate tax Not stated
Matthew Conway Latham & Watkins LLP Partner benefits and compensation Washington, D.C.
Ashlie Lawton Latham & Watkins LLP Associate benefits and compensation Not stated
Héctor Armengod Latham & Watkins LLP Partner antitrust Brussels
Ian Conner Latham & Watkins LLP Partner antitrust Washington, D.C.
Patrick English Latham & Watkins LLP Counsel antitrust Washington, D.C.
Damara Chambers Latham & Watkins LLP Partner CFIUS Washington, D.C.
Heather Deixler Latham & Watkins LLP Counsel data privacy and security Bay Area

16 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 538m (approximately US$538 million)
What the figure measures
Total transaction value
Client
Itamar MedicalSell-side
Counterparties
ZOLL Medical Corporation (Buy-side)